MeiraGTx Holdings PLCNASDAQ:MGTX
- LAST PRICE4.2600
- TODAY'S CHANGE (%)0.0800 (1.9139%)
- Bid / Lots4.1300/ 1
- Ask / Lots4.4400/ 1
- Open / Previous Close4.2600 / 4.1800
- Day Range
- 52 Week Range
- Volume105,091
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MGTX |
|---|---|---|
| 09:32 ET | 637 | 4.26 |
| 09:36 ET | 806 | 4.24 |
| 09:38 ET | 100 | 4.24 |
| 09:39 ET | 4179 | 4.26 |
| 09:41 ET | 573 | 4.255 |
| 09:43 ET | 426 | 4.29 |
| 09:45 ET | 100 | 4.27 |
| 09:48 ET | 100 | 4.28 |
| 09:50 ET | 100 | 4.26 |
| 09:52 ET | 100 | 4.26 |
| 09:54 ET | 426 | 4.24 |
| 09:56 ET | 100 | 4.235 |
| 09:59 ET | 100 | 4.26 |
| 10:01 ET | 1300 | 4.25 |
| 10:06 ET | 100 | 4.27 |
| 10:10 ET | 100 | 4.27 |
| 10:12 ET | 100 | 4.255 |
| 10:14 ET | 100 | 4.26 |
| 10:15 ET | 1000 | 4.25 |
| 10:17 ET | 484 | 4.26 |
| 10:19 ET | 1626 | 4.25 |
| 10:21 ET | 1300 | 4.25 |
| 10:24 ET | 559 | 4.26 |
| 10:26 ET | 100 | 4.25 |
| 10:28 ET | 100 | 4.25 |
| 10:30 ET | 300 | 4.26 |
| 10:32 ET | 100 | 4.28 |
| 10:33 ET | 500 | 4.265 |
| 10:35 ET | 100 | 4.28 |
| 10:37 ET | 100 | 4.27 |
| 10:39 ET | 200 | 4.27 |
| 10:42 ET | 100 | 4.27 |
| 10:44 ET | 343 | 4.28 |
| 10:46 ET | 3528 | 4.31 |
| 10:48 ET | 6006 | 4.37 |
| 10:50 ET | 2600 | 4.34 |
| 10:51 ET | 100 | 4.36 |
| 10:55 ET | 200 | 4.3203 |
| 10:57 ET | 300 | 4.32 |
| 11:02 ET | 1652 | 4.34 |
| 11:04 ET | 100 | 4.33 |
| 11:06 ET | 317 | 4.34 |
| 11:08 ET | 3922 | 4.32 |
| 11:09 ET | 100 | 4.32 |
| 11:11 ET | 1178 | 4.33 |
| 11:13 ET | 142 | 4.3499 |
| 11:18 ET | 100 | 4.36 |
| 11:20 ET | 400 | 4.3493 |
| 11:22 ET | 526 | 4.34 |
| 11:24 ET | 400 | 4.35 |
| 11:26 ET | 200 | 4.33 |
| 11:36 ET | 2286 | 4.35 |
| 11:44 ET | 100 | 4.36 |
| 11:51 ET | 100 | 4.36 |
| 11:54 ET | 400 | 4.3685 |
| 11:58 ET | 100 | 4.37 |
| 12:02 ET | 4200 | 4.36 |
| 12:05 ET | 1400 | 4.36 |
| 12:07 ET | 100 | 4.34 |
| 12:09 ET | 100 | 4.34 |
| 12:16 ET | 126 | 4.33 |
| 12:23 ET | 200 | 4.33 |
| 12:30 ET | 100 | 4.325 |
| 12:36 ET | 100 | 4.325 |
| 12:39 ET | 100 | 4.325 |
| 12:41 ET | 100 | 4.325 |
| 12:50 ET | 200 | 4.325 |
| 12:54 ET | 2203 | 4.31 |
| 01:08 ET | 500 | 4.315 |
| 01:10 ET | 400 | 4.31 |
| 01:15 ET | 2400 | 4.3 |
| 01:26 ET | 400 | 4.3 |
| 01:30 ET | 791 | 4.3089 |
| 01:32 ET | 100 | 4.3 |
| 01:37 ET | 213 | 4.3 |
| 01:39 ET | 4100 | 4.291 |
| 01:42 ET | 447 | 4.2813 |
| 01:50 ET | 300 | 4.29 |
| 01:55 ET | 600 | 4.29 |
| 01:57 ET | 100 | 4.3 |
| 02:22 ET | 400 | 4.28 |
| 02:24 ET | 100 | 4.29 |
| 02:26 ET | 247 | 4.3 |
| 02:27 ET | 500 | 4.27 |
| 02:29 ET | 200 | 4.27 |
| 02:45 ET | 300 | 4.28 |
| 02:49 ET | 100 | 4.28 |
| 02:56 ET | 100 | 4.28 |
| 03:00 ET | 100 | 4.28 |
| 03:05 ET | 100 | 4.29 |
| 03:09 ET | 300 | 4.28 |
| 03:12 ET | 134 | 4.2737 |
| 03:14 ET | 200 | 4.265 |
| 03:25 ET | 100 | 4.27 |
| 03:32 ET | 100 | 4.27 |
| 03:34 ET | 500 | 4.27 |
| 03:36 ET | 200 | 4.26 |
| 03:41 ET | 403 | 4.26 |
| 03:43 ET | 4088 | 4.26 |
| 03:48 ET | 117 | 4.25 |
| 03:54 ET | 800 | 4.255 |
| 03:56 ET | 925 | 4.26 |
| 03:57 ET | 500 | 4.265 |
| 03:59 ET | 14679 | 4.26 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
MeiraGTx Holdings PLC | 322.6M | -2.9x | --- |
Iteos Therapeutics Inc | 371.2M | -3.5x | --- |
Capricor Therapeutics Inc | 325.1M | -10.7x | --- |
XOMA Royalty Corp | 298.2M | -11.7x | --- |
Ocugen Inc | 283.7M | -5.7x | --- |
Inozyme Pharma Inc | 322.5M | -3.6x | --- |
Company Information
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.
Contact Information
- Headquarters
- 450 E 29th St Fl 15NEW YORK, NY, United States 10016-8367
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Keith Harris
- President, Chief Executive Officer, Director
- Alexandria Forbes
- Chief Financial Officer, Chief Operating Officer
- Richard Giroux
- General Counsel, Secretary
- Robert Wollin
- Chief Development Officer
- Stuart Naylor
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $322.6M |
|---|---|
Revenue (TTM) | $8.1M |
Shares Outstanding | 77.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.29 |
EPS | $-1.49 |
Book Value | $2.17 |
P/E Ratio | -2.9x |
Price/Sales (TTM) | 39.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,083.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
